Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predictors and Prognostic Factors of Myasthenia Gravis Outcome

NCT05214612 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT05214612
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05214612 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predictors and Prognostic Factors of Myasthenia Gravis Outcome
Lead sponsor
Assiut University
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2022
Completion date
March 31, 2025
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autoimmune diseases of the nervous system, myasthenia gravis, myasthenia gravis crisis, myasthenia gravis with exacerbation (disorder), myasthenia gravis, adult form, myasthenia gravis, generalized, myasthenia gravis, juvenile form, myasthenia gravis, ocular, nervous system diseases, neuromuscular junction diseases, thymoma, thymus hyperplasia